CIK 0001439222 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 54.0 M | 14.2 M | ||
| Net income (USD) | -327.4 M | -411.5 M | ||
| Diluted EPS (USD/shares) | -7.12 | -4.23 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-23 | 4 | FORM 4 | 2026-10-21 |
| 2026-10-22 | 144 | 144 | |
| 2026-10-21 | 144 | 144 | |
| 2026-08-06 | 4 | FORM 4 | 2026-08-04 |
| 2026-08-04 | 144 | 144 | |
| 2026-08-03 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-30 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-30 | 8-K | 8-K items 2.02,9.01 | 2026-07-30 |
| 2026-07-10 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-02 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-02 | 4 | FORM 4 | 2026-07-01 |
| 2026-07-01 | 144 | 144 | |
| 2026-06-23 | 4 | FORM 4 | 2026-06-18 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-18 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-18 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-18 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-18 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-18 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-18 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-18 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-18 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-18 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-18 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-18 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-18 |
Forms on file (last 1,000): 4 522, 8-K 153, SC 13G/A 69, 144 60, 10-Q 32, 3 22, DEFA14A 21, S-8 15. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=AGIO (0.002 USD), /gw/filings/filings?ticker=AGIO&form=8-K, /gw/filings/facts?ticker=AGIO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange